Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

The Development of a Shared Decision-Making Encounter Tool for Decisions of Adjuvant Treatment in Patients With Resected Non-Small Cell Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05416983

Enrollment

Registered

2022-06-14

Start date

2022-02-17

Completion date

2023-08-31

Last updated

2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Non-Small Cell Carcinoma

Brief summary

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

Detailed description

PRIMARY OBJECTIVE: I. To develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding options for adjuvant treatment in patients with resected non-small cell lung cancer (NSCL) (NSCL adjuvant choice). OUTLINE: Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire.

Interventions

PROCEDUREDiscussion

Attend discussion

OTHERQuestionnaire Administration

Complete questionnaire

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* PATIENTS: * Adults \>= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC) * Appointments to discuss adjuvant treatment of resected NSCLC * CLINICIANS: * Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC * PAG MEMBERS: * Adults \>= 18 years * Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)

Exclusion criteria

* PATIENTS * Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

Design outcomes

Primary

Measure	Time frame
Development of decision aid	Up to study completion, up to 2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026